The European inhalable drug market is anticipated to grow at a CAGR of 3.3% over the forecast period (2020-2026). The key factors that drive the growth of the market include the support by the key players functioning in the market, rising geriatric population, sedentary lifestyles, along with the change in eating habits of the people. The major countries of Europe considered in the report include the UK, France, Germany, Italy, Spain, and the Rest of Europe.
Browse the full report description Europe Inhalable Drugs Market Size, Share & Trends Analysis Report by Application (Respiratory Diseases and Non-Respiratory Diseases), By Route of Administration (Nasal and Mouth), and Forecast 2020-2026 at https://www.omrglobal.com/request-sample/europe-inhalable-drugs-market
The UK is considered a promising market for the European inhalable drug industry. According to Diabetes UK, in 2019, there were almost 3.7 million people who were diagnosed with diabetes in the country, representing 6% of the UK population. This represents 1 in every 16 people with suffer from diabetes. By 2025, it is estimated that five million people are likely to suffer from diabetes in the UK, according to Diabetes UK. This creates demand for inhalable insulin, especially among aged people, and hence creates scope for market growth.
Besides, the key player's contributions are also further driving the European market over the forecast period. F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Boehringer Ingelheim GmbH, and AstraZeneca Plc are some of the players operating in the market in the region. These players adopt several growth strategies such as product launches, innovations, mergers, and acquisitions in order to thrive in the competitive market. For instance, in February 2017, Boehringer Ingelheim Pharmaceuticals announced that the FDA approved SPIRIVA RESPIMAT, an inhalable spray, for the long-term, once-daily maintenance treatment of asthma in people age 6 and older.
Market Coverage
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected country/ segment
Europe Inhalable Drugs Market – Segmentation
By Application
By Route of Administration
Europe Inhalable Drugs Market – Countries Covered
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/industry-reports/europe-inhalable-drugs-market